Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who...
from NDTV News - Latest https://www.ndtv.com/world-news/coronavirus-gileads-remdesivir-shows-modest-improvement-in-moderate-covid-19-patients-2239077
No comments:
Post a Comment